Avanos Medical logo

Avanos MedicalNYSE: AVNS

Profile

Sector:

Healthcare

Country:

United States

IPO:

21 October 2014

Next earnings report:

20 February 2025

Last dividends:

N/A

Next dividends:

N/A
$821.25 M
-52%vs. 3y high
72%vs. sector
-85%vs. 3y high
79%vs. sector
-50%vs. 3y high
31%vs. sector
-58%vs. 3y high
27%vs. sector

Price

after hours | Wed, 20 Nov 2024 23:00:19 GMT
$17.87+$0.07(+0.39%)

Dividend

No data over the past 3 years
$170.40 M$177.23 M
$170.40 M$4.30 M

Analysts recommendations

Institutional Ownership

AVNS Latest News

Avanos Medical, Inc. to Present at the Stifel 2024 Healthcare Conference
prnewswire.com12 November 2024 Sentiment: POSITIVE

ALPHARETTA, Ga. , Nov. 12, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in an analyst-led fireside chat at the Stifel 2024 Healthcare Conference at the Lotte New York Palace in New York on Tuesday, Nov. 19 at approximately 3:35 p.m.

ON-Q* Elastomeric Infusion Pump and ambIT* Disposable Electronic Infusion Pump to Receive Separate Payment Under NOPAIN Act Starting January 1, 2025
prnewswire.com11 November 2024 Sentiment: POSITIVE

ALPHARETTA, Ga. , Nov. 11, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has issued its final Medicare Hospital Outpatient Prospective Payment System (OPPS) and Medicare Ambulatory Surgical Center (ASC) Payment System rule for 2025.

Avanos Medical Launches New CORGRIP® SR
prnewswire.com05 November 2024 Sentiment: POSITIVE

Advancement to reduce dislodgement in feeding tube retention systems ALPHARETTA, Ga. , Nov. 5, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the launch of its newly designed CORGRIP SR Nasogastric/Nasointestinal Tube Retention System, further expanding its comprehensive Enteral Feeding portfolio.

Are Investors Undervaluing Avanos Medical (AVNS) Right Now?
zacks.com31 October 2024 Sentiment: POSITIVE

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Avanos Q3 Earnings Meet Estimates, Sales Miss, Gross Margin Contracts
zacks.com31 October 2024 Sentiment: POSITIVE

Avanos Medical, Inc. AVNS reported third-quarter 2024 adjusted earnings per share (EPS) from continuing operations of 36 cents, up 20% year over year. The bottom line met the Zacks Consensus Estimate.

Avanos Medical Inc. (AVNS) Q3 2024 Earnings Call Transcript
seekingalpha.com30 October 2024 Sentiment: NEUTRAL

Avanos Medical Inc. (NYSE:AVNS ) Q3 2024 Results Conference Call October 30, 2024 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy & Corporate Development Gary Blackford - Chairman Michael Greiner - Senior VP, CFO & Chief Transformation Officer Conference Call Participants Kristen Stewart - CL King Danny Stauder - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos Third Quarter 2024 Earnings Call. [Operator Instructions] This call is being recorded on Wednesday, October 30, 2024.

Avanos Medical (AVNS) Q3 Earnings Meet Estimates
zacks.com30 October 2024 Sentiment: POSITIVE

Avanos Medical (AVNS) came out with quarterly earnings of $0.36 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.30 per share a year ago.

Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2024 Financial Results
prnewswire.com23 October 2024 Sentiment: POSITIVE

ALPHARETTA, Ga. , Oct. 23, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2024 on Wednesday, Oct. 30 at 9 a.m.

Avanos Medical (AVNS) Upgraded to Strong Buy: What Does It Mean for the Stock?
zacks.com17 October 2024 Sentiment: POSITIVE

Avanos Medical (AVNS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Reasons to Add Avanos Medical Stock in Your Portfolio Now
zacks.com03 October 2024 Sentiment: POSITIVE

AVNS's strong product line and focus on R&D raise optimism about the stock.

  • 1(current)
  • 2
  • 3

What type of business is Avanos Medical?

Avanos Medical, Inc. offers a wide range of products focused on respiratory and digestive health; pain management solutions; as well as minimally invasive interventional methods for pain treatment, closed suction systems for airways, and enteral feeding tubes. The company also offers Game Ready products for pain relief and rehabilitation of patients recovering from orthopedic surgeries or sports injuries; GRPro 2.1 cold and compression therapy system; Med4Elite, a multimodal therapy block; ATX wraps; and various accessories for products. Additionally, it sells its products under the brands ON-Q, COOLIEF, MICROCUFF, MIC-KEY, HOMEPUMP, CORTRAK, and GAME READY. Avanos Medical, Inc. was registered in 2014 and is headquartered in Alpharetta, Georgia.

What sector is Avanos Medical in?

Avanos Medical is in the Healthcare sector

What industry is Avanos Medical in?

Avanos Medical is in the Medical Devices industry

What country is Avanos Medical from?

Avanos Medical is headquartered in United States

When did Avanos Medical go public?

Avanos Medical initial public offering (IPO) was on 21 October 2014

What is Avanos Medical website?

https://avanos.com

Is Avanos Medical in the S&P 500?

No, Avanos Medical is not included in the S&P 500 index

Is Avanos Medical in the NASDAQ 100?

No, Avanos Medical is not included in the NASDAQ 100 index

Is Avanos Medical in the Dow Jones?

No, Avanos Medical is not included in the Dow Jones index

When was Avanos Medical the previous earnings report?

No data

When does Avanos Medical earnings report?

The next expected earnings date for Avanos Medical is 20 February 2025